New Title

Patient Information - Your Body, Your Decision

Learn more about breast surgery using GC Aesthetics implants. In this PDF, you will learn more about breast surgery, as well as read about the experiences of other women who have already realized their dreams!

Comfort Plus Replacement Guarantee - GCA Breast Implants

Learn how the lifetime warranty for GC Aesthetics breast implants works.

The Round Collection by GCA - Microtextured Round Breast Implant

The Round Collection line - Our most widely used implant worldwide! It offers a variety of options to suit different body types and preferences, promoting comfort, balance, and a bolder or more natural breast shape, according to your preference and aligned with how you want to feel every day from now on.

Perle by GCA - Opaque Smooth Breast Implant

The PERLE line is our smooth, opaque round implant. Developed in line with the most modern safety guidelines. It is available in a variety of volumes and projections. Experience the Art of Science with our PERLE implant.

Impleo by GCA - Textured Round Breast Implant

Impleo is GC Aesthetics's (GCA) line of textured implants. The product is designed to provide optimal fit and a natural appearance. It is an implant with a balance between smoothness and shape stability.

Luna XT by GCA - Microtextured Anatomical Breast Implant

Luna XT: Naturalness, safety, and elegance in a single implant. The only anatomical implant with MDR certification, microtextured, with multiple projections and a lifetime warranty.

Blossom - Tissue Expander with Integrated Valve

Specifications, measurements, and volumes of the Blossom IVTE (integrated Valve Tissue Expander).

Renuve - Tissue expander with remote valve

Specifications, measurements, and volumes of RVTE (Remote Valve Tissue Expander) tissue expanders. Available in various shapes and volumes (round, rectangular, cylindrical, semi-lunar, and others).

Healena by GCA

A single-use, multi-layered adhesive dressing, composed of microperforated silicone strips and a polyurethane covering (film), which ensures uniform adhesion, contraction, and continuous compression on the incision. It also has UV filters, is almost imperceptible, and allows the patient to shower without worry. All this guarantees patient satisfaction and the best aesthetic results in wound healing.

Patient guide and consent form for breast augmentation.

At the end of this file, there is a template for a free and informed consent form to add to the patient's file after informing them of all the benefits, risks, and safety aspects of the procedure.

Ten-Year Safety Data for Eurosilicone's Round and Anatomical Silicone Gel Breast Implants

Franck Duteille, MD; Pierre Perrot, MD; Marie-Hélène Bacheley, MSc; Erin Bell, BSc; and Sharon Stewart, PhD Abstract: Although silicone breast implants have been available for over 60 years, their safety and efficacy continue to be assessed via long-term clinical and surveillance studies. Complications often associated with breast implant surgery include but are not limited to capsular contracture and rupture. Objective: The authors investigate and evaluate the safety and performance of Eurosilicone's (Eurosilicone SAS, Apt Cedex, France) Cristalline Paragel breast implants at least 10 years postimplantation. Methods: Nine hundred and ninety-five of Eurosilicone's textured mammary implants were implanted in 526 women undergoing primary (423 patients) and revision surgery (103 patients) at 17 centers throughout France. Complications were recorded at 3 months and annually thereafter for 10 years. Descriptive statistics were used and the Kaplan-Meier method was utilized to analyze key complications. Results: Seventy-four women (98 implants) experienced capsular contracture across all cohorts. The Kaplan-Meier 10-year cumulative risk of capsular contracture (Baker Grade III/IV) per implant was 11.5% in the primary augmentation cohort and 25.2% in the primary reconstruction cohort. Sixteen implant ruptures were observed by surgeon examination giving a Kaplan-Meier risk of 3.8% per patient and 3.5% per implant. Surgical re-intervention (explantation/exchange) was reported 80 times resulting in a Kaplan-Meier cumulative risk of 13.3% and 31.6% for primary augmentation and primary reconstruction, respectively, per patient. Local complication rates including infection and seroma were low with risk rates of 0.6% and 0.2% by subject. Conclusions: This multicenter clinical study demonstrates the long-term safety and efficacy profile through 10 years for Eurosilicone round and anatomical silicone gel breast implants.Level of evidence 3 (Therapeutic)

Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants - William P. Adams, Jr., MD

William P. Adams, Jr., MD Eric J. Culbertson, MD Anand K. Deva, FRACS Mark R. Magnusson, MD Craig Layt, FRACS (Plast) Mark L. Jewell, MD Patrick Mallucci, MD, FRACS (Plast) Per Hedén, MD Background: Bacteria/biofilm on breast implant surfaces has been implicated in capsular contracture and breast implant–associated anaplastic large-cell lymphoma (ALCL). Macrotextured breast implants have been shown to harbor more bacteria than smooth or microtextured implants. Recent reports also suggest that macrotextured implants are associated with a significantly higher incidence of breast implant–associated ALCL. Using techniques to reduce the number of bacteria around implants, specifically, the 14-point plan, has successfully minimized the occurrence of capsular contracture. The authors hypothesize that a similar effect may be seen in reducing the risk of breast implant–associated ALCL. Methods: Pooled data from eight plastic surgeons assessed the use of macrotextured breast implants (Biocell and polyurethane) and known cases of breast implant–associated ALCL. Surgeon adherence to the 14-point plan was also analyzed. Results: A total of 42,035 Biocell implants were placed in 21,650 patients; mean follow-up was 11.7 years (range, 1 to 14 years). A total of 704 polyurethane implants were used, with a mean follow-up of 8.0 years (range, 1 to 20 years). The overall capsular contracture rate was 2.2 percent. There were no cases of implant–associated ALCL. All surgeons routinely performed all 13 perioperative components of the 14-point plan; two surgeons do not routinely prescribe prophylaxis for subsequent unrelated procedures. Conclusions: Mounting evidence implicates the role of a sustained T-cell response to implant bacteria/biofilm in the development of breast implant–associated ALCL. Using the principles of the 14-point plan to minimize bacterial load at the time of surgery, the development and subsequent sequelae of capsular contracture and breast implant–associated ALCL may be reduced, especially with higher-risk macrotextured implants. (Plast. Reconstr. Surg. 140: 427, 2017.) CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

Croma Saypha Rich Technical Data Sheet

Croma Saypha Rich is an injectable viscoelastic solution of non-crosslinked hyaluronic acid (HA), ideal for deep hydration (skin booster), improved tone and elasticity, and filling of fine wrinkles (crow's feet, smile lines). It contains a high concentration of HA and glycerol for rejuvenation and radiance, making it ideal for facial areas, neck, and décolleté. Key Features and Benefits: Deep Hydration: Combats HA loss and intensely hydrates the skin. Rejuvenation (Skin Booster): Improves elasticity, firmness, and tone. Gentle Filling: Ideal for fine lines and superficial wrinkles. Formula: High molecular weight non-crosslinked hyaluronic acid (18 mg/mL) combined with glycerol, which acts as a moisturizing agent. Procedure: Generally applied to the superficial dermis in 3 sessions with 21-day intervals. Safety: Croma Pharma product with high safety and purity standards. Indications: Crow's feet, expression lines, fine wrinkles. Revitalization of facial skin, neck and décolleté. Improvement of skin texture and radiance. The product is indicated for professional use in a clinic, being considered a high-tech, biocompatible and safe filler.

Croma Saypha Filler Technical Data Sheet

Croma's Saypha Filler is a high-quality monophasic hyaluronic acid filler indicated for the correction of moderate to severe wrinkles, facial lines, and lip contouring/volume. It utilizes SMART technology (low BDDE concentration), offering high molecular weight, greater stability, durability, and smooth application (low extrusion force). Key Features and Benefits: Indication: Wrinkles, lines, lip contouring and volume. Application: Mid to deep dermis. Technology: SMART (acronym for Safe Hyaluronic Acid Cross-linked Technology), which reduces inflammatory processes. Versions: Available with and without lidocaine (lido) for greater comfort. Manufacturer: Croma Pharma (Austria). Croma Saypha Line (Context): Saypha Filler: Wrinkle and lip filling. Saypha Volume: Volumizing areas, dark circles, and facial contouring. Saypha Volume Plus: Deep structuring, rhinoplasty. Saypha Rich: Hydration and superficial wrinkles. This product is a medicine and its use is restricted to qualified healthcare professionals.

Croma Saypha Volume Technical Data Sheet

Saypha Volume by Croma is a monophasic, cross-linked hyaluronic acid dermal filler, ideal for restoring facial volume, reshaping contours, and correcting deep wrinkles/furrows. It utilizes SMART technology for high stability, safety, and natural results. Generally available in syringes. Main Features and Benefits: Indication: Volume augmentation (cheeks, chin), facial contouring, and treatment of pronounced furrows. Application: Deep dermis, subcutaneous, or supraperiosteal. Technology: Advanced cross-linking (SMART) that reduces the inflammatory process and increases durability. Composition: High-purity hyaluronic acid, available with or without lidocaine (generally) for greater comfort during application. Results: Naturalness, deep hydration, and skin support. The product is for exclusive use by qualified healthcare professionals. The Saypha line also includes Volume Plus for more severe volumetric deficits.

Croma Saypha Volume Plus Lido Technical Data Sheet

Croma Saypha Volume Plus Lidocaine (1ml) is a high-density hyaluronic acid filler from Croma Pharma, indicated for restoring severe facial volume, defining contours (such as jawline and chin), and treating lipoatrophy. It utilizes SMART technology for greater stability and contains 0.3% lidocaine for comfort during application. Main characteristics and indications: Application: Ideal for areas with severe volume deficiency in the midface, zygomatic-malar region, and submalar region, with deep subcutaneous or supraperiosteal injection. Technology: Cross-linked hyaluronic acid with high volumizing capacity and cohesiveness. Comfort: Contains 0.3% lidocaine, reducing pain during the procedure. Safety: Must be applied by qualified healthcare professionals. Contraindications: Should not be injected into the periorbital region (tear trough, eyelids), glabella, or nasal ala. Note: It is important to consult a healthcare professional for application, as its sale is restricted and requires technical knowledge.